News - Page 7 of 7 - Australasian Kidney Trials Network (AKTN)

No benefit from drug used to reduce heart disease in kidney patients

September 14, 2020 aktnadmin

A large-scale clinical trial finds lanthanum carbonate does not reduce the risk of cardiovascular disease developing in patients with chronic kidney disease.The drug is routinely

Continue reading
BEST-Fluids study – recruitment complete

August 12, 2020 aktnadmin

We are delighted to announce that recruitment for BEST-Fluids is now complete, with 808 participants enrolled. Congratulations to all the study teams for your hard

Continue reading
get involved – goal trial consumer advisory board

July 20, 2020 aktnadmin

Let’s hear the patient voice Are you a patient or carer who would like to be involved in how clinical trials are designed? We’d love

Continue reading
MRFF funding success

June 30, 2020 aktnadmin

The IMPEDE-PKD and M-FIT trials have been successful in receiving funding via the Medical Research Future Fund (MRFF) rare cancers, rare diseases and unmet needs

Continue reading
Kidney medication ineffective

June 25, 2020 aktnadmin

A major clinical trial run by the AKTN finds the drug allopurinol does not prevent worsening of kidney disease. University of Queensland researchers at the

Continue reading
COVID19 response – update from the AKTN

May 25, 2020 aktnadmin

Continue reading

Dr Andrea Viecelli wins two coveted awards

June 6, 2018 aktnadmin

AKTN nephrologist and researcher wins two coveted awards – the European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) Young Investigator Award 2018 and The

« 1 … 5 6 7